Circulating heparin-like substance after liver injury

Factors influencing hydrocarbon degradation in three freshwater lakes.

Microbial ecology·2013

[A modified in vivo platelet retention test in the evaluation of primary hemostasis].

Schweizerische medizinische Wochenschrift·1987

Monitoring of heparin therapy with the activated partial thromboplastin time and chromogenic substrate assays.

Thrombosis and haemostasis·1987

[Blood coagulation disorders].

Schweizerische medizinische Wochenschrift·1987

Exposure of platelet binding sites in von Willebrand factor by adsorption onto polystyrene latex particles.

Biochimica et biophysica acta·1987

Three abnormal fibrinogen variants with the same amino acid substitution (gamma 275 Arg----His): fibrinogens Bergamo II, Essen and Perugia.

Thrombosis and haemostasis·1986

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Factor XI Inhibition for Ischemic Stroke Secondary Prevention: Pharmacology, Clinical Evidence, and Future Directions.

Journal of clinical pharmacology·2026

Hyaluronic Acid in the Management of Foot and Ankle Pathologies.

Foot & ankle specialist·2026

Audit and Evaluation of the Effect of Fresh Frozen Plasma and Adjunct Pharmacological Agents (Vitamin K1, Prothrombin Complex Concentrate, Tranexamic Acid, and Recombinant Factor VIIa) on Pre- and Post- Transfusion INR in Patients with Coagulopathy: A Prospective Study.

Journal of pharmacy & bioallied sciences·2026

Temporal phosphoproteomics reveals key regulators of procoagulant COAT platelet generation.

Blood vessels, thrombosis & hemostasis·2026

Molecular control of platelet extravasation into tumors and its impact on tumor growth.

Blood vessels, thrombosis & hemostasis·2026

Augmenting hemopexin-mediated heme scavenging mitigates sepsis-induced acute kidney injury in humanized sickle cell mice.

Blood vessels, thrombosis & hemostasis·2026

Related Experiment Videos

Circulating heparin-like substance after liver injury

Related Concept Videos

Factors influencing hydrocarbon degradation in three freshwater lakes.

[A modified in vivo platelet retention test in the evaluation of primary hemostasis].

Monitoring of heparin therapy with the activated partial thromboplastin time and chromogenic substrate assays.

[Blood coagulation disorders].

Exposure of platelet binding sites in von Willebrand factor by adsorption onto polystyrene latex particles.

Three abnormal fibrinogen variants with the same amino acid substitution (gamma 275 Arg----His): fibrinogens Bergamo II, Essen and Perugia.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Factor XI Inhibition for Ischemic Stroke Secondary Prevention: Pharmacology, Clinical Evidence, and Future Directions.

Hyaluronic Acid in the Management of Foot and Ankle Pathologies.

Audit and Evaluation of the Effect of Fresh Frozen Plasma and Adjunct Pharmacological Agents (Vitamin K1, Prothrombin Complex Concentrate, Tranexamic Acid, and Recombinant Factor VIIa) on Pre- and Post- Transfusion INR in Patients with Coagulopathy: A Prospective Study.

Temporal phosphoproteomics reveals key regulators of procoagulant COAT platelet generation.

Molecular control of platelet extravasation into tumors and its impact on tumor growth.

Augmenting hemopexin-mediated heme scavenging mitigates sepsis-induced acute kidney injury in humanized sickle cell mice.

Related Experiment Videos

Circulating heparin-like substance after liver injury

Related Concept Videos

Related Articles